Phase 3 Readout~month

Phase 3 Topline: A Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Toler

Indication
Multiple Sclerosis

Other upcoming events for IMUX

Phase 3 ReadoutPhase 3 Topline: A Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Toler

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Toler — IMUX Phase 3 Readout | BioSniper